AOTI Launches NEXA NPWT System to American Market

• By Laurie Watanabe
• Jun 08, 2023

AOTI introduced the NEXA Negative Pressure Wound Therapy (NPWT) system to the United States market during this week’s WOCNext conference in Las Vegas, Nev.

At the Wound, Ostomy, and Continence Nurses Society conference (WOCNext), AOTI showed off the system it described as “an incredibly flexible platform that is simple to use, silent, portable and affordable. NEXA seamlessly combines the simplicity of disposable NPWT with the performance features of more traditional durable NPWT technology platforms.”

Dr. Mike Griffiths, AOTI’s President/CEO, said in a June 7 announcement, “Releasing the innovative NEXA NPWT platform in the USA is a major milestone for the company that will allow clinicians, payers, and patients alike to experience much improved performance at significantly lower cost. With NEXA, we have reimagined how NPWT should function. Its addition to our portfolio only further enhances our mission of helping all people with chronic conditions get back to living their lives to the fullest.”

AOTI described the NEXA NPWT system and Topical Wound Oxygen (TWO2) therapy as “unlike any other treatment options. NEXA provided unrivaled flexibility and performance in a portable NPWT system. TWO2 is the only device that provides a multimodality treatment, combining higher pressure oxygen delivery with non-contact cyclical compression and humidity, in a therapeutic applied by the patient at home. This patented approach has been demonstrated in numerous Randomized Controlled Trial and Real World Evidence studies to not only heal chronic wounds at a far higher rate, but perhaps more importantly, keep them closed longer term, thereby reducing unnecessary hospitalizations and amputations.”

AOTI is based in Oceanside, Calif., and Galway, Ireland.